Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04908631 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of tDCS to Enhance Auditory Rehabilitation in Cochlear Implant Recipients
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04908631: Completed NA study, sponsored by Duke University.
NCT04908631 is a NA study that has completed, run by Duke University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04908631, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study aims to evaluate the safety and feasibility of transcranial direct current stimulation (tDCS) in combination with home-based auditory training therapy in cochlear implant (CI) patients. Changes in speech perception performance will also be evaluated.
Interventions
- DEVICE Transcranial Direct Stimulation
- OTHER Auditory Training Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2024-07-29 |
| Phase | NA |
What the finished NCT04908631 record still lists
NCT04908631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Transcranial Direct Stimulation is the first listed.
NCT04908631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04908631 about?
NCT04908631 is a clinical study titled "Safety and Feasibility of tDCS to Enhance Auditory Rehabilitation in Cochlear Implant Recipients". This study aims to evaluate the safety and feasibility of transcranial direct current stimulation (tDCS) in combination with home-based auditory training therapy in cochlear implant (CI) patients. Changes in speech perception performance will also be evaluated.
What is the current status of trial NCT04908631?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-03-15. Estimated completion is 2024-07-29.
What interventions are being tested in trial NCT04908631?
The interventions under investigation include: Transcranial Direct Stimulation (DEVICE), Auditory Training Program (OTHER).
Who is sponsoring clinical trial NCT04908631?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04908631's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI